The Bioactive Gamma-Oryzanol from Oryza sativa L. Promotes Neuronal Differentiation in Different In Vitro and In Vivo...

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Gamma-oryzanol (ORY) is a rice-derived compound known for antioxidant and anti-inflammatory properties.
• Previous studies indicated ORY positively impacts cognitive function, synaptic plasticity, and neuroprotection in adult mice.
• This research investigates the neuro-differentiating potential of ORY.

Purpose of the Study:

• To explore the neuro-differentiating effects of gamma-oryzanol (ORY) using diverse experimental models.
• To identify key components of ORY and their role in neurogenesis.
• To elucidate the molecular mechanisms underlying ORY's neuro-differentiating actions, particularly the involvement of the Nrf2 pathway.

Main Methods:

• Chemical characterization of ORY to identify major components.
• In vitro studies using human neuroblastoma cells to assess neurite outgrowth and gene expression (GAP43, BDNF, TrkB).
• In vitro studies with adult mouse hippocampal neural progenitor cells (NPCs) to evaluate neuronal commitment.
• In vivo studies using zebrafish models (Tg(neurog1:GFP) and nrf2 morphants) to analyze gene expression (neurog1, islet1, bdnf) and Nrf2 pathway involvement.
• Computational analysis of ORY components' affinity for the Keap1-Kelch domain.

Main Results:

• ORY stimulated neurite outgrowth and upregulated GAP43, BDNF, and TrkB gene expression in human neuroblastoma cells.
• ORY guided mouse hippocampal NPCs toward neuronal differentiation.
• In zebrafish, ORY increased neurog1-GFP, islet1, and bdnf mRNA levels.
• ORY's induction of bdnf was dependent on the Nrf2 pathway, as it was abolished in nrf2a and nrf2b morphants.
• Computational analysis suggested differential binding affinities of ORY components to Keap1.

Conclusions:

• Gamma-oryzanol (ORY) exhibits significant neuro-differentiating potential across multiple experimental models.
• The Nrf2 pathway is crucial for mediating ORY's ability to activate bdnf expression.
• ORY represents a promising source of bioactive compounds for neurological applications, warranting further investigation.